Introducing BioSpace’s 2026 40 Under 40 Winners
Congratulations to our 2026 cohort! These young leaders hail from a range of business functions and highlight the values 40 Under 40 is designed to celebrate.
BioSpace’s 40 Under 40 honors 40 exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. All under the age of 40, these young leaders already demonstrate our industry’s values of innovation, impact and commitment to improving outcomes for patients.
BioSpace’s 40 Under 40 honors 40 exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. All under the age of 40, these young leaders already demonstrate our industry’s values of innovation, impact and commitment to improving outcomes for patients.
-
Director, Business Development and Alliance Management
Scribe Therapeutics -
Director, In Vivo Discovery
Kite Pharma, a Gilead company -
Senior Director, Head of Biology
Maze Therapeutics -
Vice President, Application Development
Generate:Biomedicines -
Co-Founder and CEO
Strand Therapeutics -
Executive Director, Head of AI Drug Discovery Analytics
Revolution Medicines -
Global Head of Insights, Digital and Analytics
Gilead Sciences -
Senior Vice President, Discovery Systems
OmniAb -
CEO
Coastar Therapeutics -
CEO and Founder
Biorce -
Senior Director, Team Lead and Chief of Staff
Marea Therapeutics -
Senior Vice President, Global Medical Affairs and Advocacy
Enable Injections -
Co-Founder and CEO
Inductive Bio -
Principal
Flagship Pioneering -
Vice President, Strategy and Operations
Renasant Bio -
Chief Financial Officer and Head of Corporate Development
Enliven Therapeutics -
Chief Platform Officer
Dispatch Bio -
Vice President of Corporate Strategy
Azalea Therapeutics -
Senior Principal Scientist
Bristol Myers Squibb -
Chairman, President and CEO
CG Oncology -
Director, Program Management
Avid Bioservices -
Senior Director, Business Development, Altos Labs
Vice President, Milky Way Investments -
CEO
Radar Therapeutics -
Co-Founder and Advisor
Transcend Therapeutics -
Chief Technology Officer
Terray Therapeutics -
Co-Founder and CEO
Mammoth Biosciences -
Associate Director–Research, Data Science and AI
Boehringer Ingelheim -
Director of Health Advocacy
Genentech, a member of the Roche Group -
Associate Director, Biologics Drug Product Development
Teva Pharmaceuticals -
Senior Director, Research and Development
Slingshot Biosciences -
Vice President, Early Clinical Development
Bicara Therapeutics -
Chief Operating Officer
GondolaBio -
Director, Operations
Hikma Pharmaceuticals -
Vice President of Business and Strategy
Forge Biologics -
Vice President, CMC
Abcentra -
CEO and Co-Founder
Bexorg -
Enterprise Strategic Operations
Parabilis Medicines -
Chief Medical Officer
Pelage Pharmaceuticals -
Chief Scientific Officer
Tahoe Therapeutics -
Executive Director and Evanesco Program Lead
BridgeBio
About 40 Under 40
Eligibility Guidelines
In order to be eligible, the nominee:
- Must be based in the U.S.
- Must be 39 years of age or younger for the entire calendar year for which they are considered
- Must work in a leadership role in any size biotech or pharma company operating in the U.S.
- Must still be employed at the company for which they were nominated when winners are announced
Judging Criteria
BioSpace’s committee will be looking for evidence of the nominee’s achievements in each selection criteria:
- Vision and innovation
How has this individual’s vision or innovative thinking influenced their company’s practices? - Business impact
How has this individual contributed toward their company meeting business objectives? - Leadership
How do this individual’s leadership qualities impact their team and the wider organization? Industry? Community? - Commitment to health equity and serving patients
How do this individual’s accomplishments serve patients and contribute to improving health equity?
Selection Process
- Anyone can nominate an individual for consideration
- Nominees are required to complete an online submission
- Nominations open in July
- All submitted material is confidential and will be reviewed solely by BioSpace
- All winners will be notified by September
- Announcements will be made in October
